Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Verastem
Pharma
Roche, Asahi Kasei, Verastem—Fierce Pharma Asia
Roche inked a $1.2 billion obesity deal with China's Rona. Asahi Kasei won a first-in-class FDA nod. Verastem's KRAS drug showed strong early data.
Angus Liu
Oct 16, 2026 7:57am
Verastem mulls options on approved asset in pancreatic cancer
Jun 17, 2026 3:00pm
Verastem starts campaign to move cancer drugs into earlier lines
May 1, 2026 4:12am
Verastem nixes KRAS G12C plans in non-small cell lung cancer
Jan 2, 2026 10:10am
FDA approves Verastem's combo for rare form of ovarian cancer
May 9, 2025 10:42am
Verastem sets first awareness day for rare ovarian cancer
Sep 3, 2024 3:20pm
